Atlas Trials

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

Clinical trial NCT00189930 · COMPLETED

Trial details

NCT number
NCT00189930
Sponsor
Bavarian Nordic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infection
Start date
2005-04-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.